drugset / Trial / NCT04634227
Gemcitabine Plus Ascorbate for Sarcoma in Adults (Pilot)
NaSingle-groupOpen-labelTreatment
Summary
This study will enroll patients who have a diagnosis of locally advanced, unresectable or metastatic soft tissue or bone sarcoma (except gastrointestinal stromal tumors and Kaposi's sarcoma) from any site.
Timeline
- Start
- 2020-11-24
- Primary completion
- 2025-03-18
- Completion
- 2026-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vitamin C | Other / unclassified | 75 g | Intravenous |